Physician profile
Amanda Ewing
NPI 1841673688
$1,037.20
in general payments reported to CMS, 2019-2025
18 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298 · 2022: $232 · 2023: $279 · 2024: $66.30 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.70 | 2021-2025 | |
| Galderma Laboratories, L.P. | $161.36 | 2021-2023 | Dysport |
| Avanir Pharmaceuticals, INC. | $79.80 | 2021-2022 | |
| Glaxosmithkline, LLC. | $60.12 | 2023-2024 | Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $59.00 | 2021-2022 | |
| Amgen INC. | $42.53 | 2022-2023 | Otezla, Repatha |
| Xeris Pharmaceuticals, INC. | $40.75 | 2023 | Keveyis, Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $34.29 | 2023-2025 | Nuedexta, Rexulti |
| Revance Therapeutics, INC. | $29.14 | 2025 | Daxxify |
| Lilly USA, LLC | $27.17 | 2021-2022 | |
| Astellas Pharma US INC | $24.91 | 2025 | Veozah |
| Genentech USA, INC. | $20.29 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.79 | 2022 | |
| Pfizer INC. | $18.13 | 2023 | |
| Genzyme Corporation | $16.73 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.22 | 2024 | Airsupra |
| Allergan, INC. | $12.35 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.